> New big news of SVA putting seasonal flu and H1N1 vaccines together
> into a single vaccine to be launched next year. This new dual vaccine
> is really big news for SVA and its shareholders, and puts the Nasdaq
> listing (with possible fundraising) and quiet stakebuilding into
> perspective.
> The current share price will be remembered with a fondness in the next
> few years :-)

> Great news indeed, bluepeter!  Thanks!

> H1N1 vaccine and common flu vaccine to merge
> (chinadaily.com.cn)
> Updated: 2009-11-06 15:18

> Sinovac Biotech Co Ltd is doing research to merge the A(H1N1) flu
> vaccine and traditional flu vaccine into one, qianlong.com reported
> Friday.

> Also, from an article entitled "Novartis Looking to Cut into H1N1
> Vaccine Market in China"
> Fri. November 06, 2009; Posted: 06:17 AM

> The global vaccine market is expected to surge to EUR 18 billion in
> 2012, with influenza vaccine growing at the fastest pace, predicted
> vaccine maker Sanofi Pasteur. Lehman Brothers Holdings Inc. (NYSE:
> LEH) anticipated that global vaccine sales revenue would increase 18%
> year by year, far exceeding an estimated 4.4% annual growth of the
> entire pharmaceutical industry.

> Looking ahead, Sinovac Biotech will launch more products to come up
> with the mounting demand for H1N1 vaccine amid the lingering HIN1
> pandemic influenza in the world, said Yin Weidong, chief executive
> officer, chairman, and president for the company.

> On Nov 6, 4:32 am, bluepeter <davidsbluebe...@googlemail.com> wrote:

> > New big news of SVA putting seasonal flu and H1N1 vaccines together
> > into a single vaccine to be launched next year. This new dual vaccine
> > is really big news for SVA and its shareholders, and puts the Nasdaq
> > listing (with possible fundraising) and quiet stakebuilding into
> > perspective.
> > The current share price will be remembered with a fondness in the next
> > few years :-)